KRAS and neoplasm: Therefore, in addition to the inactivation of Apc, activation of ERK signaling, either by the activation of SHP-2 as demonstrated herein or by mutation of KRAS [49], appears to act synergistically resulting in increased tumor multiplicity in the intestine.